Quantcast


Insect cells provide the key to alternative swine flu vaccination

January 4, 2010
biotech

[NEWS]

Contact: Ben Norman Benorman@wiley.com 44-124-377-0375 Wiley-Blackwell New production method can meet the demand of a global flu pandemic Scientists in Vienna have developed a new technique for producing vaccines for H1N1, 'swine flu', based on insect cells. The research, published today in the <e…


How to build bone: Separate bone formation from bone destruction

January 4, 2010
biotech

[NEWS]

Contact: Karen Honey press_releases@the-jci.org 215-573-1850 Journal of Clinical Investigation Treatments for osteoporosis (a disease characterized by reduced bone density, which leads to an increased risk of fracture) need to increase the amount and/or quality of bone. As bone formation is tightly coupled to bone destruction, researchers …


Virus may chauffeur useful ‘packages’ into plants

January 4, 2010
biotech

[NEWS]

Contact: Kathleen Phillips ka-phillips@tamu.edu 979-845-2872 Texas A&M AgriLife Communications COLLEGE STATION – This time of year, the word “virus” conjures up a bedridden stint with coughs and chills – something everyone goes to great lengths to avoid. But scientists for Texas AgriLife Research have gone the distan…


Trod Medical builds outpost in Manatee County

January 2, 2010
biotech

Paris-based Trod Medical has opened it’s US headquarters in Bradenton. The office will be primarily sales and administration for the …Click Here to Read More


HealthChem Diagnostics to build manufacturing facility in St. Lucie

January 2, 2010
biotech

The Economic Development Council of St. Lucie County, Inc. (EDC) has assisted in the expansion to St. Lucie County of …Click Here to Read More


Carbon nanotubes show promise for high-speed genetic sequencing

December 31, 2009
biotech

[NEWS] Contact: joe Caspermeyer joseph.caspermeyer@asu.edu 480-258-8972 Arizona State University Faster sequencing of DNA holds enormous potential for biology and medicine, particularly for personalized diagnosis and customized treatment based on each individual’s genomic makeup. At present however, sequencing technology remains cumberso…


Genetics: Monogamouse

December 30, 2009
biotech

Genetically modified prairie voles may illuminate the human condition

LOVE, of course, is what makes the world go round, but what makes love go round? To aesthetes, such a question is imponderable. To scientists, it is not only ponderable but increasingly open to scrutiny—the more so now that Zoe Donaldson and her colleagues at Emory University in Atlanta, Georgia, have succeeded in creating a new kind of transgenic prairie vole. For, unlikely as it might seem, these tiny rodents could be the key to understanding bonding, trust and even decision-making in humans.

For those unfamiliar with the delightful prairie vole, it is a small rodent found in the grasslands of central North America. What makes it unusual among mammals is that it is both sociable and monogamous. Prairie voles groom each other, nest with one another, collaborate to guard their territory and are affectionate and attentive parents who form, for the most part, devoted couples. Their close relatives the meadow voles, by contrast, prefer a solitary, promiscuous existence. …


Defense Department to Support Fragile X Research

December 29, 2009
biotech

[NEWS]

WASHINGTON, Dec. 29 /PRNewswire-USNewswire/ — The National Fragile X Foundation applauds the United States Congress and President Barack Obama for including Fragile X Syndrome for the first time ever within a select group of conditions eligible for research funding from the U.S. Department of Defense. The new law, signed by President Obama on Dec. 19, designates $50 million through the FY 2010 Department of Defense Appropriations Act for the Peer Reviewed Medical Research Program (PRMRP). Fragil…


New research could advance research field critical to personalized medicine

December 29, 2009
biotech

[NEWS]

Contact: Karen Mallet km463@georgetown.edu 215-514-9751 Georgetown University Medical Center Washington, DC — It's the ultimate goal in the treatment of cancer: tailoring a person's therapy based on his or her genetic makeup. While a lofty goal, scientists are steadily moving forward, rapidly exploiting new technologies. Researc…


Scripps research team develops technique to determine ethnic origin of stem cell lines

December 29, 2009
biotech

[NEWS]

Contact: Keith McKeown kmckeown@scripps.edu 858-784-8134 Scripps Research Institute Cells more representative of the US and world populations could lead to more accurate research and safer, more effective therapies An international team of scientists led by researchers at The Scripps Research Institute has developed …